Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Grade

About Corbus Pharmaceuticals Holdings, Inc.'s fundamentals

Corbus Pharmaceuticals is a small-cap biotechnology company with a market capitalization of $108.4 million that is not yet profitable, having reported a net loss in its latest annual statement. The company generated no revenue growth year-over-year and maintains a net margin of 0.0%, indicating it is currently operating at a loss. With no dividend yield and negative profitability metrics, the company's financial performance reflects the typical characteristics of an early-stage biotech firm that has not yet achieved sustained commercial success.